Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America
Albert Prats-Uribe, Anthony G. Sena, Lana Yin Hui Lai, Waheed-Ul-Rahman Ahmed, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Carlos Areia, William Carter, Paula Casajust, Dalia Dawoud, Asieh Golozar, Jitendra Jonnagaddala, Paras P. Mehta, Mengchun Gong, Daniel R. Morales, Fredrik Nyberg, Jose D. Posada, Martina Recalde, Elena Roel, Karishma Shah, Nigam H. Shah, Lisa M. Schilling, Vignesh Subbian, David Vizcaya, Andrew Williams, Lin Zhang, Ying Zhang, Hong Zhu, Li Liu, Peter Rijnbeek, George Hripcsak, Jennifer CE Lane, Edward Burn, Christian Reich, Marc A. Suchard, Talita Duarte-Salles, Kristin Kostka, Patrick Ryan, Daniel Prieto-Alhambra
medRxiv 2020.09.15.20195545; doi: https://doi.org/10.1101/2020.09.15.20195545
